Ledger.Open graph →
SEC Form D · Amendment · filed December 14, 2018

EpiVax Oncology, Inc

Offering
$2.0M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PROVIDENCE, RI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gad Berdugo · Providence, RIExecWilliam Martin · Providence, RIExec · DirectorAnne De Groot · Providence, RIExec · DirectorMartin A. Klingel, Jr · Charlottesville, VAExec · DirectorWilliam J. Gordon, Jr · Charlottesville, VAExecG. R. Zage · ALPHARETTA, GAExec · DirectorJames H. Whitcomb · Atlanta, GAExec · DirectorMaya Capital Ventures GP I, LLC · SAO PAULO, GuernseyExecRakesh Malhotra · Wakefield, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗